Your session is about to expire
← Back to Search
PET/MRI with [18F]FTC-146 for Chronic Pain
Study Summary
This trial will compare how much of a certain drug collects in healthy people vs. people with chronic pain, in order to learn more about chronic pain.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- I have been experiencing chronic pain for more than 2 months.I have been experiencing chronic pain for more than 2 months.If you don't speak English, you cannot participate as a healthy volunteer.My pain level is at least 4 out of 10.I do not speak English.I am a healthy volunteer with a recent negative Covid test, regardless of vaccination status.I am 18 years old or older and experiencing pain.My pain level is at least 4 out of 10.I am a healthy volunteer experiencing pain.I am a healthy volunteer not on pain medication.You cannot participate if you are a healthy volunteer and cannot have an MRI.I am 18 years old or older.You cannot have an MRI scan because of the type of pain you have.If you feel very uncomfortable in small or enclosed spaces.If you are uncomfortable in small, enclosed spaces, you cannot participate as a healthy volunteer.I am a healthy volunteer and I am 18 years old or older.You need to have a negative Covid test within 72 hours of the scan, regardless of whether you have been vaccinated or not.If you're getting a scan and have pain, you need to have a negative Covid test within 3 days, no matter if you've been vaccinated or not.
- Group 1: Pain Patients
- Group 2: Healthy Volunteers
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there still openings for participation in this research study?
"Affirmative. Clinicaltrials.gov provides evidence that this clinical trial, which was initially published on July 16th 2018 and recently modified on October 31st 2022, is currently recruiting participants. In total, 190 people need to be recruited from a single research centre."
How many participants are taking part in this trial?
"Affirmative. Clinicaltrials.gov reveals that this trial, which was initially posted on July 16th 2018 is presently recruiting participants. 190 patients are being sought out at a single site of the study's origin."
Are the effects of [18F]FTC-146 on patients well understood?
"Given the limited evidence surrounding [18F]FTC-146's safety and efficacy, our team assigned it a score of 1 on a scale from 1 to 3."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger